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AIM To establish the incidence of infantile spasms in children in the southern region of the
Republic of Ireland and to compare the incidence of infantile spasms before and after the
introduction of therapeutic hypothermia in infants with hypoxic-ischemic encephalopathy
(HIE).
METHOD Children born between 2003 and 2015 and diagnosed with infantile spasms
(epileptic spasms with or without hypsarrhythmia) in the first 2 years of life were identified
through audits of electroencephalography reports and paediatric neurology patient lists. Data
on live births were obtained from the regional hospital statistics databases. Medical charts of
infantile spasm cases were reviewed for demographic information, diagnostic workup
results, treatment response, disease course, and developmental outcome.
RESULTS Forty-two infants with infantile spasms were identified. The cumulative incidence of
infantile spasms up to the age of 2 years was 4.01 per 10 000 live births. Difference due to
sex was minimal (22 males, 20 females) and most infants were delivered at or near term with
gestational ages ranging between 30.0 and 41.8 weeks (median [interquartile range] 39.6wks
[38.1–40.0wks]). The aetiology for infantile spasms was identified in almost two-thirds of
cases, with HIE being the single most common cause (n=7). Other causes included
chromosomal and monogenetic abnormalities (n=8). Infantile spasms occurred in moderate
and severe grades of HIE, with a significantly higher incidence in those with severe HIE
(p=0.029). Infants with severe HIE who did not receive therapeutic hypothermia were six
times more likely to develop infantile spasms compared to those who did, but the difference
was not statistically significant (4 out of 16 vs 1 out of 24, p=0.138).
INTERPRETATION This study provides detailed information about infantile spasms before and
after the introduction of therapeutic hypothermia. HIE severity is a risk factor for the
development of infantile spasms. The introduction of therapeutic hypothermia may have had
an impact, but the effect was hard to ascertain in this cohort due to the small number of
infants.
Infantile spasms were first reported by Dr West in 1841.1
Historically, infantile spasms and West syndrome have often
been used synonymously. Current established terminology
describes West syndrome as a subset of infantile spasms,
consisting of the combination of spasms and a hypsarrhyth-
mic electroencephalogram (EEG) (Fig. S1, online support-
ing information). Often, but not necessarily, they are
accompanied by developmental delay and/or regression.2–4
Infantile spasms are described as an age-specific epileptic
encephalopathy, with a clinically distinguished seizure type,
which may or may not be accompanied by the characteristic
EEG findings of hypsarrhythmia.5 Infantile spasms have an
estimated incidence of 2 to 5 per 10 000 live births.6 Spasms
typically present as clusters of sudden brief flexion, exten-
sion, or mixed extension–flexion contractions of proximal
and truncal muscles, followed by a sustained tonic phase
lasting up to 2 seconds.3,7,8 These often resolve over time,
but up to 50% of patients develop other types of refractory
epilepsy syndromes, such as Lennox–Gastaut syndrome.9
Infantile spasms are further categorized into two sub-
groups: infantile spasms with a known and clearly identifi-
able cause (formerly known as symptomatic), including
metabolic, structural, and genetic causes; and infantile
spasms of unknown cause.10,11 A better prognosis is
reported in the majority of patients in the latter sub-
group.5,12 Hypoxic-ischemic encephalopathy (HIE) forms
the major aetiology of infantile spasms,13 but limited
research that evaluates the effect of therapeutic hypother-
mia on the incidence and outcome of infantile spasms has
been published.14
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Early diagnosis and treatment of infantile spasms are
believed to improve outcome, especially if started within
the first month of the onset of spasms.12 The aims of treat-
ment are to obtain spasm cessation, normalize the EEG,
and achieve better long-term developmental outcomes.
Treatment options consist of standard first-line pharmaco-
logical agents, including hormonal therapy and vigabatrin,
and non-standard options including other medications, a
ketogenic diet, and surgical intervention.3 Because of the
rarity of the disorder, experimental trials are difficult to
perform and are therefore limited.
In this study, we describe the overall incidence, causes,
and disease outcomes of infantile spasms in infants born
between January 2003 and December 2015 in the southern
region of the Republic of Ireland.
Therapeutic hypothermia was introduced into neonatal
intensive care across the Republic of Ireland in 2009.
Therefore, for infants with moderate and severe HIE, we
also examined any possible effect(s) of therapeutic
hypothermia on the incidence of infantile spasms in infants
with a history of HIE.
METHOD
This was a retrospective observational study conducted at
Cork University Hospital and Mercy University Hospital,
the only two hospitals with paediatric neurology depart-
ments covering the southern territories of the Republic of
Ireland. For the purposes of this study, the term ‘infantile
spasms’ will be used to describe epileptic spasms character-
ized by sudden brief movements of the trunk and limbs,
with a flexor, extensor, or mixed pattern developing in
infants within the first 2 years of life, with or without the
presence of classic hypsarrhythmia or its variants (modified
hypsarrhythmia) on EEG.5,7 Where applicable, patients
diagnosed with infantile spasms were divided into those
with hypsarrhythmia and those without, where classic hyp-
sarrhythmia is represented by an interictal EEG with a
chaotic high voltage background pattern intermixed with
generalized and multifocal discharges, and modified hyp-
sarrhythmia corresponds to hypsarrhythmia with atypical
features (focal or asymmetrical, episodic attenuation, or
interhemispheric synchronization).15–17
Children with infantile spasms were identified in two
stages. First, through an audit of EEG reports from the
neurophysiology departments of the two hospitals (Cork
University Hospital and Mercy University Hospital) that
provide services to the region. This was done by a com-
puter search of EEG reports, extending from January 2003
to December 2017, using the following keywords: hypsar-
rhythmia, spasm, infantile, West, salaam/salam, and epilep-
tic encephalopathy. All EEG recordings were reviewed and
reported by a consultant clinical neurophysiologist (BM).
The second stage of the audit was completed at the paedi-
atric neurology departments at Cork University Hospital
and Mercy University Hospital, whose staff are responsible
for the follow-up of all children with new-onset seizures in
the region. Paediatric neurologists (NM, OO) and clinical
nurse specialists in epilepsy identified additional patients
missed in the first stage of our search. Children born in or
admitted to any of the Cork maternity hospitals with ter-
tiary neonatal units between January 2003 and December
2015, with a confirmed diagnosis of infantile spasms within
2 years of birth, were included in the study. (During the
2003 to 2007 period, there were two maternity hospitals
with level 3 neonatal units covering Cork city: Erinville
Hospital and St. Finbarr’s Maternity Hospital. After amal-
gamation in March 2007, Cork University Maternity
Hospital became solely responsible for maternity and
neonatal admissions in the area). Data regarding the num-
ber of live births in the region were available from 2006
onwards from Cork University Hospital Perinatal Statistics
(2005–2016). Thus, for the purpose of calculating cumula-
tive incidence, children born after 2005 and diagnosed with
infantile spasms were included.
Next, an audit review of the medical charts of infants
diagnosed with infantile spasms was completed and the fol-
lowing data were collected: demographics including date of
birth, sex, birthweight, gestational age, neonatal course,
and family history of seizure disorder or developmental
delay; initial investigations including EEG reports; and
aetiological testing results. Aetiological tests included brain
imaging, and genetic and metabolic workup. Metabolic
workup was individualized and tailored to each patient.
Investigations included lactate, ammonia, amino acids, cre-
atine kinase, urate, urinary purines and pyrimidines, uri-
nary organic acids, biotinidase, mucopolysaccharides,
acylcarnitine, lysosomal enzymes and very-long-chain fatty
acids, and cerebrospinal fluid neurotransmitters. Genetic
testing in the earlier period of the study comprised kary-
otyping; later on, comparative genomic hybridization
microarray was introduced. In more recent years (2010
onwards), early epileptic encephalopathy gene panels have
been used. Depending on the results of aetiological testing,
patients were divided into infantile spasms of known aetiol-
ogy and infantile spasms of unknown aetiology. This study
was approved by the Clinical Research Ethics Committee
of the Cork Teaching Hospitals.
Treatment response
Treatments were decided by the attending paediatric neu-
rologist, taking into account associated comorbidities and
parental preferences; response to treatment was assessed
within 2 weeks of initiation. Infants were classified into
two groups based on their response: non-responders, if
there was minimal to no effect after 2 weeks of treatment;
and responders, if there was resolution of both the spasms
What this paper adds
• The incidence of infantile spasms and patient characteristics in the southern
region of the Republic of Ireland is similar to internationally published data.
• None of the infants with a history of mild hypoxic-ischemic encephalopathy
(HIE) developed infantile spasms.
• The risk of infantile spasms was higher in infants with severe HIE.
• Infantile spasms were more frequent in infants with severe HIE not treated
with therapeutic hypothermia.
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and the electrographic abnormalities persisting for longer
than 6 weeks. If no follow-up EEG was reported, response
was based on clinical cessation of spasms.
Disease course including age of diagnosis and disease
outcome
Disease outcome was described with regard to subsequent
epilepsy, progression to Lennox–Gastaut syndrome, death,
and developmental outcome. Lennox–Gastaut syndrome
was defined as infants having multiple types of seizures
(mainly tonic and atypical absence seizures), being unre-
sponsive to treatment and having slow spike-and-wave dis-
charges and paroxysmal generalized fast activity on EEG
(Fig. S1), and intellectual delay.18,19 Refractory epilepsy
was used for infants with ongoing epilepsy (at the time of
data collection) despite multiple treatment trials (three or
more antiepileptic medications). Development was
assessed by paediatric neurologists (NM, OO) on follow-
up, under the four major domains: gross motor; fine
motor and vision; speech and hearing; and social skills.
Infants were considered to have global developmental
delay if two or more developmental domains were
affected.
Infants with HIE
During the period from 2003 to 2006, infants with a
diagnosis of HIE were prospectively recruited at the
Cork Teaching Hospitals, to research projects approved
by the Clinical Research Ethics Committee of the Cork
Teaching Hospitals, involving continuous EEG monitor-
ing and long-term follow-up assessments of neonates at
high risk of seizures.20 Between 2008 and 2015, the total
number of infants admitted with HIE was obtained from
the Cork University Maternity Hospital In-Patient
Enquiry scheme database (data were not available for
2007). Data including sex, gestational age, clinical grade
of encephalopathy (Sarnat staging),21 and therapy received
(therapeutic hypothermia vs no therapeutic hypothermia)
were recorded for infants diagnosed during the aforemen-
tioned periods. From 2009 onwards, the decision to
administer therapeutic hypothermia was based on Sarnat
staging, with moderate and severe grades of HIE under-
going treatment as per the TOBY study.22 Access to
neonatal clinical and research EEGs and postneonatal fol-
low-up EEGs carried out on an outpatient basis was
available for the purposes of this review.
Statistical analysis
Statistical analysis was performed with IBM SPSS Statis-
tics version 24.0 (IBM Corp., Armonk, NY, USA). Cumu-
lative incidence was calculated as the proportion of
infants diagnosed with infantile spasms up to the age of
2 years among live births. A 95% confidence interval (CI)
for the cumulative incidence was calculated using a bino-
mial distribution (Clopper–Pearson exact method). For
the descriptive analysis of normally distributed continuous
variables, the mean and SD were used; for non-normally
distributed variables, the median and interquartile
range (IQR) were used. Categorical variables were
described using frequencies and percentages. Fisher’s exact
test was used for the comparative analysis of categorical
variables between groups; the Mann–Whitney U test was
used for the comparative analysis of continuous, non-nor-
mally distributed variables between groups. All tests were
two sided and a p-value less than 0.05 was considered to
be statistically significant.
RESULTS
During the study period, 47 infants had a confirmed diag-
nosis of infantile spasms within 2 years of birth. Of those,
five were born outside the study area and were excluded
from the study. Thus, 42 infantile spasm cases were
included in the study analysis. Thirteen infants developed
different types of seizures before the onset of infantile
spasms, including 10 who had seizures during the neonatal
period (first 28d of life). The age at infantile spasm diag-
nosis ranged from 6 weeks to 21 months.
Of the 42 infants, 33 were born during the years 2006
to 2015, the years for which data regarding the number
of live births were available. Accordingly, the cumulative
incidence of infantile spasms up to the age of 2 years
among live births was 4.01 per 10 000 (95% CI=2.76–
5.63). The yearly cumulative incidence varied, with the
highest occurring in 2013, reaching 8.43 per 10 000
(Table 1).
Demographics
The number of males and females was similar (Table 2).
Twenty-four infants were delivered by vaginal delivery
and 18 by Caesarean section. Gestational age varied
between 30.0 and 41.8 weeks. Only 5 infants were deliv-
ered preterm (<37wks), including a set of twins. Fourteen
infants had a positive family history of epilepsy, four had
a family member with febrile convulsions, and eight had
a family relative with developmental delay or learning
difficulties.
Table 1: Yearly cumulative incidence of infantile spasms up to the age of













2006 6090 24 6066 3 4.95
2007 7998 39 7959 1 1.26
2008 8778 43 8735 2 2.29
2009 8978 44 8934 1 1.12
2010 8898 43 8855 2 2.26
2011 8786 30 8756 6 6.85
2012 8563 32 8531 3 3.52
2013 8339 32 8307 7 8.43
2014 8071 39 8032 3 3.74
2015 8113 38 8075 5 6.19
Total 82 614 364 82 250 33 4.01 (2.76–5.63)b
aInclusive of stillbirths and neonatal deaths. b95% confidence interval.
Source: Cork University Hospital Perinatal Statistics, 2005 to 2016.
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Neonatal course
Over half of the infants (n=24) were admitted to the
neonatal unit after delivery; HIE was the most common
reason for admission (n=7; Table 2).
Neonatal EEGs were recorded in 12 infants: 10 were
initiated for clinical purposes (and later enrolled in
research projects) and two as part of a research project
only. All 10 infants who had a clinically indicated EEG,
had suspected seizures for which they were treated.
Among those, electrographic seizures were documented
in six.
Aetiology of infantile spasms
All infants were investigated to determine a possible aetiol-
ogy. Forty-one patients had a brain MRI and one had a
computed tomography scan performed. Metabolic testing
and karyotyping/comparative genomic hybridization
microarray were performed for all patients who had no
apparent abnormality on brain imaging; an epilepsy gene
panel was sent for five patients.
Based on aetiological testing, 27 infants had a known
aetiology (Table 2). Various causes were identified, with
HIE being the most predominant (n=7), followed by tri-
somy 21 and brain malformations (n=5 each). Brain mal-
formations included lissencephaly, polymicrogyria, Miller–
Dieker syndrome, Aicardi syndrome, and holoprosen-
cephaly. Three infants were diagnosed with tuberous scle-
rosis and three others had genetic epileptic
encephalopathies identified (1p36 deletion, 15q duplica-
tion, and CDKL5 mutation). Less frequent aetiologies
were periventricular leukomalacia, brain tumour (left tem-
poroparietal desmoplastic infantile ganglioglioma), neona-
tal stroke (left middle cerebral artery territory), and
neonatal meningitis (group B Streptococcus), (n=1 each).
EEG findings at the time of infantile spasms
Thirty-eight infants had hypsarrhythmia (28 classical and
10 modified; Table 2). The remaining four infants diag-
nosed with infantile spasms presented with clinical events
and abnormal EEGs but no hypsarrhythmia. They were
divided as follows: in the group of infantile spasms of
unknown aetiology (n=15), three had an epileptic EEG but
no hypsarrhythmia; in the group of infantile spasms of
known aetiology (n=27), only one had a non-hypsarrhyth-
mic EEG. The latter infant had a history of HIE and had
received therapeutic hypothermia; his EEG was diffusely
encephalopathic.
Pharmacological therapy
The most common first-line treatment was vigabatrin
(n=25), followed by prednisolone (n=15), both dosed
according to the United Kingdom Infantile Spasms Study
protocol.23 The response rates for vigabatrin and pred-
nisolone were 8 out of 25 and 5 out of 15 respectively.
Two infants (one from each group) were switched to a dif-
ferent medication due to side effects. Other first-line treat-
ments were sodium valproate given to an infant with
trisomy 21, and levetiracetam prescribed for focal seizures
coexisting with spasms, before starting vigabatrin (n=1
each).
One-third of infants (n=13) responded to the first-line
medication. Three infants had no records of follow-up
EEG after their infantile spasm diagnosis, two died after
redirection of care, and one child moved to another neu-
rology centre outside the region. All three had no clinical
response to their first-line medication.
Second- and third-line medications included those from
first-line choices, as well as adrenocorticotropic hormone,
clonazepam, topiramate, and clobazam. Fifteen infants








Sex (male), n (%) 22 (52.2) 12 (80.0) 10 (37.0) 0.011
Birthweight (kg), median (IQR) 3.5 (2.9–3.7) 3.5 (3.2–3.7) 3.4 (2.9–3.7) 0.844b
Gestational age (wk), median (IQR) 39.6 (38.1–40.0) 38.7 (37.0–40.0) 39.7 (38.6–40.0) 0.323b
Neonatal intensive care unit admission, n (%) 24 (57.1) 5c (33.3) 19d (70) 0.027
Infantile spasm age of diagnosis (mo), median (IQR) 7.0 (5.0–11.0) 8.0 (6.0–11.0) 7.0 (5.0–10.0) 0.257b
Hypsarrhythmia, n (%) 38 (90.5) 12e (80.0) 26f (96.3) 0.122
Duration of follow-up (mo), median (IQR) 61.2 (22.6–84.2) 44.3 (23.0–67.4) 63.4 (20.0–90.2) 0.684b
Epilepsy post-infantile spasms, n (%) 28 (66.7) 8 (53.3) 20 (74.1) 0.193
Lennox–Gastaut syndrome, n (%) 6 (14.3) 2 (13.3) 4 (14.8) 1
Global developmental delay, n (%) 35 (83.3) 10 (66.7) 25 (92.6) 0.077
Final outcome – – – 0.016
Resolved infantile spasms/epilepsy, n (%) 19 (45.2) 11 (73.3) 8 (29.6) 0.010
Resolved epilepsy, n (%) 11 (26.2) 3 (20.0) 8 (29.6) 0.717
Death, n (%) 12 (28.6) 1 (6.7) 11 (40.7) 0.031
aFisher’s exact test, unless otherwise stated. bMann–Whitney U test. cCauses of admission: poor feeding (n=1); jaundice (n=1); preterm
birth (n=2); non-clinical reasons, maternal cardiomyopathy requiring stay in intensive care (n=1). dCauses of admission: respiratory distress
(n=6); hypoxic-ischemic encephalopathy (n=7); perinatal asphyxia (n=1); sepsis (n=1); poor feeding (n=1); preterm birth (n=1); bloody stool
for further investigations (n=1); antenatally diagnosed cardiac lesions for echocardiography (n=1). eOf the 12 infants, seven had classical
hypsarrhythmia and five had modified hypsarrhythmia. fOf the 26 infants, 21 had classical hypsarrhythmia and five had modified hypsar-
rhythmia. IQR, interquartile range.
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received pyridoxine as part of their treatment protocol; 19
infants required three or more medications during the
course of their illness.
Disease outcome
Infants were followed up for a median (IQR) of
61.2 months (22.6–84.2mo) from the time they were diag-
nosed until the end of the study period or the date of
death (where applicable). Two-thirds (n=28) developed
other forms of epilepsy after infantile spasms. Six were
diagnosed with Lennox–Gastaut syndrome. The remainder
(n=22) developed focal (n=4), typical/atypical absence
(n=2), tonic (n=2), atonic (n=1), generalized tonic–clonic
(n=3), and myoclonic seizures (n=5), and combinations of
two or more of the aforementioned types of seizures (n=5).
Regarding development, 35 infants were globally
delayed, including 12 infants diagnosed with cerebral palsy,
11 had spastic quadriplegic cerebral palsy, and 1 had hemi-
plegic cerebral palsy. Comorbidities included visual impair-
ment (n=9), microcephaly (n=8), autism (n=4), and
sensorineural hearing loss (n=2). Seven infants did not have
global developmental delay; of these, four had language
delay and attended speech and language therapy. The per-
centage of infants with global developmental delay was
higher in the infantile spasms of known aetiology group
compared to the infantile spasms of unknown aetiology
group, but the difference was not statistically significant
(25 out of 27 vs 10 out of 15, p=0.077).
At the time of the study, 12 infants had died between the
ages of 6 months and 10 years (median [IQR]: 24.5mo
[21.0–70.7mo]) and this percentage was higher in the infan-
tile spasms of known aetiology group compared to the infan-
tile spasms of unknown aetiology group (11 out of 27 vs 1
out of 15, p=0.031). Of the surviving infants (n=30), 19 had
resolved spasms/epilepsy and 11 had refractory epilepsy.
Infantile spasms secondary to HIE
A total of 178 infants with HIE were admitted to the
neonatal units during the 2003 to 2006 and 2008 to 2015
periods (74 females, 104 males). Their clinical HIE grades
were divided as follows: 49 mild; 89 moderate; and 40
severe. Seventy-eight out of 178 received therapeutic
hypothermia.
Among the 178 infants with HIE, seven developed infan-
tile spasms (four males, three females), giving a cumulative
incidence of 3.93% (95% CI=1.60–7.93). The infants with
infantile spasms secondary to HIE (n=7) had neonatal
EEG recordings consistent with severe encephalopathy
(burst suppression pattern and/or isoelectric trace; Fig. S1).
All seven infants developed clinical seizures and five had
documented electrographic seizures during their neonatal
intensive care unit stay. The remaining two infants with no
recorded electrographic seizures had already received
antiepileptic drugs before the start of EEG monitoring.
Brain MRI revealed marked abnormality in the parietal
lobes and basal ganglia in five infants, and extensive bilat-
eral injury to the cortical and subcortical areas and deep
grey matter involvement in two infants.
The seven infants with later infantile spasms had moder-
ate-to-severe Sarnat staging of HIE as neonates, with the
degree of severity significantly increasing the risk of infan-
tile spasm development. Of the 40 infants with severe HIE,
five developed infantile spasms; of the 89 infants with mod-
erate HIE, only two developed infantile spasms (12.5% vs
2.2%, p=0.029). Taking into consideration that therapeutic
hypothermia may affect the outcome, we looked at
untreated infants only and compared the incidence of infan-
tile spasms between the severe and moderate groups; a sta-
tistically significant difference remained between the two
groups (4 out of 16 vs 1 out of 37, p=0.025; Fig. 1).
In the infants with severe HIE, 24 received therapeutic
hypothermia and 16 did not (12 were born before its intro-
duction and four were not treated because of preterm birth
or delayed diagnosis/transfer). Infants with severe HIE
who did not receive therapeutic hypothermia were six
times more likely to develop infantile spasms compared to
those who did, but the difference was not statistically sig-
nificant (4 out of 16 vs 1 out of 24, p=0.138; relative
risk [95% CI]: 0.17 [0.02–1.36]). For infants with moder-
























Figure 1: Percentages of infantile spasms (IS) among moderate and severe hypoxic-ischemic encephalopathy (HIE) in Cork (2003–2006 and 2008–2015).
Flow chart of infants with moderate and severe HIE showing the highest percentage of later infantile spasm development in the severe/no therapeutic
hypothermia (TH) subgroup.
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between untreated and treated infants (1 out of 37 vs 1 out
of 52, p=1). Of the seven infants with infantile spasms sec-
ondary to HIE, the five infants who did not receive thera-
peutic hypothermia died by the age of 7 years, while the
two treated infants survived but had global developmental
delay and epilepsy.
DISCUSSION
We have shown that the cumulative incidence rate of
infantile spasms in the southern region of the Republic of
Ireland is 4.01 per 10 000 live births. HIE continues to be
a major cause of infantile spasms, with the severity of HIE
staging linked to the incidence of infantile spasms as a
long-term outcome. Outcome and response to treatment
remain poor in patients with infantile spasms, with nearly a
third dying before the age of 10 years.
Results from our study showed cumulative incidence
rates, sex, age at which spasms were diagnosed, and devel-
opmental outcomes that are comparable to previously pub-
lished data.6,9,12,24–26 Infantile spasms are more commonly
seen in infants born at term than in infants born preterm,
possibly reflecting the effect of brain maturation on the
risk of spasm development. Prior studies documented that
infants born preterm formed only 5% of the total numbers
of infantile spasm patients,13,27 whereas our cohort had a
relatively higher percentage of 12%.
A clear aetiology was identified in almost two-thirds of
infants, as is the case in similar observational cohorts.13,24
In the United Kingdom Infantile Spasms Study, HIE was
reported as the most common cause of infantile spasms,
accounting for 10% of all aetiologies.13 Likewise, HIE was
observed to be the most common cause of infantile spasms
in our group. Trisomy 21 formed another major subset,
which could be explained by the high prevalence rate of
trisomy 21 in Ireland, recently estimated at 35.7 out of
10 000 births.28 In our cohort, only five infants had an epi-
lepsy gene panel investigated, which could explain the lim-
ited number of documented genetic mutations reported in
this study. Nowadays, epilepsy gene panels form an inte-
gral part of the investigative process. Furthermore, whole-
genome sequencing has been explored for possible use in
patients who have had negative genetic diagnosis through
early-onset epileptic encephalopathy panels and has shown
promising results.29
In the group under study, almost all infants were started
on either vigabatrin or steroids after diagnosis, and similar
response rates were found for both, which is contradictory
to previous evidence of better response with hormonal
treatment.23 Recent reports indicate that dual therapy (viga-
batrin and steroids) is more effective than hormonal therapy
alone, having a higher rate of spasm cessation and a shorter
response time.30 Impact on neurodevelopment with this
therapeutic approach will need further exploration.
Poor long-term outcomes in infants with infantile spasms
are well documented, with a large proportion progressing
to other seizure types, often resistant to treatment.3 Addi-
tional association with developmental delay and/or
regression further worsens the prognosis.12,31 Follow-up
data from our study group demonstrated that over 80% had
global developmental delay and almost one-third of infants
died before the age of 10 years, with a significantly higher
rate in the infantile spasms of known aetiology group. A
quarter of our cohort developed refractory epilepsy and six
were diagnosed with Lennox–Gastaut syndrome.
Since they were first described in 1841, infantile spasms
have been extensively studied, yet the exact pathophysio-
logical changes leading to spasm development remain
obscure. Various animal models mimicking the pathogenic
mechanisms of infantile spasms have been developed. Pro-
posed mechanisms include stress-induced hyper-excitabil-
ity, loss of inhibitory neurons, and significant damage to
cortical and subcortical regions.32
Hypoxic brain injury in early life is a predisposing factor
for infantile spasms. The pattern of injury on neuroimag-
ing has been assessed to establish which infants are at
greatest risk of developing infantile spasms. Gano et al.33
followed up a cohort of 176 infants with a history of HIE,
eight of which developed infantile spasms. On comparing
the neonatal MRI scans of infants with HIE who devel-
oped infantile spasms versus those who did not, basal gan-
glia/thalamic injury, along with brainstem and extensive
cortical involvement, were highly associated with later
development of spasms. Similarly, the neuroimaging results
in our cohort of seven showed basal ganglia involvement in
the majority (5 out of 7) and considerable bilateral cortical
injury in the remainder.
Since 2009, evidence of the positive impact of therapeu-
tic hypothermia on the mortality and developmental out-
comes in HIE has been well substantiated.34 Therapeutic
hypothermia was also proven to reduce the incidence of
later epilepsy, but limited results are reported on its rela-
tion to infantile spasms.35 Among our HIE subset, direct
correlation between spasm development and the severity of
HIE (as per Sarnat staging) was demonstrated. The num-
ber of infants treated with therapeutic hypothermia who
went on to develop spasms was appreciably lower than
infants not treated with therapeutic hypothermia, yet the
difference did not reach statistical significance.
With colocated paediatric and neonatal neurophysiology
units, we had the opportunity to follow infants with a his-
tory of HIE who underwent neonatal EEG monitoring
into their childhood years, with the ability to track changes
on their EEG starting from the neonatal period through to
the development of hypsarrhythmia and beyond, which
makes this study unique.
The main limitation of this study was the cohort size.
Since the cohort was small, the statistical tests had low
power. Given the rarity of this disorder and relatively small
number of cases, this is not surprising. In the group of
infants with a history of HIE, only seven went on to
develop infantile spasms; therefore, the effect of therapeu-
tic hypothermia was difficult to ascertain. A much larger
cohort is needed to prove/disprove a beneficial role of
therapeutic hypothermia on later infantile spasms.
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For the purpose of this study, we described the charac-
teristics of infantile spasm cases and their outcome, with
the emphasis on the degree of HIE injury and possible
effects of therapeutic hypothermia in the HIE-affected
subgroup. Future plans are to look at the neonatal course
in more depth, including a thorough evaluation and
description of EEG recordings during the neonatal period,
to help identify any baseline features predictive of the later
development of infantile spasms.
Our study results indicate that, in the post-therapeutic
hypothermia era, HIE remains a leading cause of infantile
spasms with an identified aetiology. We have determined
that infants with severe HIE and severe EEG abnormalities
in the neonatal period are at the greatest risk. We propose
that larger, multicentre studies are required to examine the
effect of therapeutic hypothermia on infantile spasm risk in
this subgroup.
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RESUMEN
IMPACTO DE LA HIPOTERMIA COMO TRATAMIENTO EN LOS ESPASMOS INFANTILES: UN ESTUDIO DE COHORTE OBSERVACIONAL
OBJETIVO Establecer la incidencia de los espasmos infantiles en ni~nos de la Republica de Irlanda y comparar la incidencia de los
espasmos infantiles antes y despues de la introduccion de la hipotermia terapeutica en ni~nos con encefalopatıa hipoxico-
isquemica (EHI).
METODO Ni~nos nacidos entre 2003 y 2015 y diagnosticados con espasmos infantiles (espasmos epilepticos con o sin hipsarritmia)
en los primeros 2 a~nos de vida fueron identificados por medio de auditorıas de reportes de electroencefalograficos y listas de
pacientes de neurologos infantiles. Datos sobre los nacidos vivos se obtuvieron de la base de datos estadıstica del hospital
regional. Las historias clınicas de los casos de espasmos infantiles fueron revisadas para obtener datos demograficos, resultados
diagnosticos, respuesta a tratamiento, curso de la enfermedad y resultados del desarrollo.
RESULTADOS Fueron identificados 42 ni~nos con espasmos infantiles. La incidencia acumulada de los espasmos infantiles por
encima de los 2 a~nos fue de 4,01 por 10.000 nacidos vivos. La diferencia debida al sexo fue mınima (22 masculinos, 20 femeninos)
y la mayorıa nacieron en o cercano a termino, con edad gestacional entre 30,0 y 41,8 semanas (media (rango Intercuartil) 39,6
semanas (38,1-40,0 semanas). La etiologıa de espasmos infantiles fue identificada en dos tercios de los casos, siendo EHI la causa
mas comun (7 de 42). Otras causas incluyeron anormalidades cromosomicas y monogenicas (8 de 42). Los espasmos infantiles
ocurrieron en los grados moderados y severos de EHI con incidencia significativamente mayor en aquellos casos severos de EHI
(p=0,029). Los ni~nos con EHI severo que no recibieron hipotermia terapeutica tuvieron una probabilidad seis veces mayor de
desarrollar espasmos infantiles comparados con aquellos quienes la recibieron, pero la diferencia no era estadısticamente
significativa (4 de 16 vs 1 de 14, p=0,138).
INTERPRETACION Este estudio proporciona informacion detallada acerca de los espasmos infantiles antes y despues de la
introduccion de la hipotermia terapeutica. La severidad de la EHI es un factor de riesgo para el desarrollo de los espasmos
infantiles. La introduccion de la hipotermia terapeutica puede haber tenido un impacto, pero el efecto fue difıcil de determinar en
esta cohorte debido al peque~no numero de recien nacidos.
RESUMO
IMPACTO DA HIPOTERMIA TERAPÊUTICA NOS ESPASMOS INFANTIS: UM ESTUDO DE COORTE OBSERVACIONAL
OBJETIVO Estabelecer a incidência de espasmos infantis em criancas da Republica da Irlanda e comparar a incidência de
espasmos infantis antes e apos a introduc~ao da hipotermia terapêutica em lactentes com encefalopatia hipoxica-isquêmica (EHI).
METODO Criancas nascidas entre 2003 e 2015 e diagnosticadas com espasmos infantis (espasmos epilepticos com ou sem
hipsarritmia) nos primeiros 2 anos de vida foram identificadas por meio de checagem dos relatorios de eletroencefalografia e
listas de pacientes de neurologia pediatrica. Dados sobre nascidos vivos foram obtidos nas bases de dados estatısticas dos
hospitais regionais. Prontuarios medicos sobre casos de espasmos infantis foram revisados quanto a dados demograficos,
resultados diagnosticos, resposta ao tratamento, curso da doenca, e resultado desenvolvimental.
RESULTADOS Quarenta e dois lactentes com espasmos infantis foram identificados. A incidência cumulativa de espasmos infantis
ate os dois anos de idade foi 4,01 por 10.000 nascidos vidos. Diferencas devida ao sexo foram mınimas (22 meninos, 20 meninas)
e a maior parte dos lactentes nasceu proximo ao termo, com idades gestacionais variando de 30,0 41,8 semanas (mediana
[intervalo interquartil] 39,6 sem [38,1–40,0sem]). A etiologia dos espasmos infantis foi identificada em dois tercos dos casos, com
a EHI sendo a causa mais comum (7 em cada 42). Outras causas incluıram anormalidades cromossômicas e monogeneticas (8 em
42). Os espasmos infantis aconteceram em graus moderados a severos de EHI, com incidência significantemente maior naqueles
com EHI severa (p=0,029). Lactentes com EHI severa que n~ao receberam hipotermia terapêutica tinham seis vezes mais
probabilidade de desenvolver espasmos infantis comparados com os que receberam, mas a diferenca n~ao foi estatisticamente
significativa. (4 em16 vs 1 em 24, p=0,138).
INTERPRETAC~AO Este esudo fornece informac~ao detalhada sobre espasmos infantis antes e apos a introduc~ao de hipotermia
terapêutica. A severidade da EHI e um fator de risco para o desenvolvimento de espasmos infantis. A introduc~ao de hiportermia
terapêutica por ter tido um impacto, mas o efeito foi difıcil de assegurar nesta coorte devido ao pequeno numero de lactentes.
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